Supplemental Oxygen in Pulmonary Fibrosis
|ClinicalTrials.gov Identifier: NCT01961362|
Recruitment Status : Completed
First Posted : October 11, 2013
Last Update Posted : May 4, 2017
|Condition or disease|
The investigators aim to recruit patients with PF to participate in interviews and/or a one-year study of supplemental oxygen (O2). In the one-year study, the investigators will collect data before and for one year after PF patients are prescribed daily-use supplemental oxygen and compare outcomes, including shortness of breath, quality of life, fatigue, cough, and day-to-day functioning before and after O2.
In addition to this, the investigators will interview O2 prescribers and primary supporters/caregivers of PF patients prescribed daily-use O2 to understand the perceptions of others affected by supplemental O2.
|Study Type :||Observational|
|Actual Enrollment :||360 participants|
|Official Title:||Observing the Effects of Supplemental Oxygen on Patients With Pulmonary Fibrosis|
|Study Start Date :||October 2013|
|Primary Completion Date :||December 2016|
|Study Completion Date :||December 2016|
Pulmonary fibrosis patients
Patients with pulmonary fibrosis of any cause (idiopathic, connective tissue disease, chronic hypersensitivity pneumonitis)
Primary supporter/caregiver of patient with pulmonary fibrosis
We will interview primary supporters/caregivers of people living with PF to learn from a different perspective of what it's like to use supplemental oxygen, both for the person living with PF and the primary supporter him/herself.
Prescribers of supplemental oxygen
We will interview supplemental oxygen prescribers to better understand their practices around prescribing oxygen and their expectations for the patients to whom they prescribe supplemental oxygen.
- Change in dyspnea from immediately prior to one month after starting daily-use supplemental oxygen [ Time Frame: One month post daily-use supplemental oxygen implementation ]
- Change in quality of life, fatigue and cough from prior to one month after daily-use supplemental oxygen implementation [ Time Frame: One month after daily-use supplemental oxygen implementation ]
- Change in day-to-day functioning and activity space from prior to one month after daily-use supplemental oxygen implementation [ Time Frame: One month after daily-use supplemental oxygen implementation ]Functioning will be captured by having patients wear an activity monitor, and activity space will be capture by having patients wear a mobile GPS recorder.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01961362
|United States, Colorado|
|National Jewish Health Interstitial Lung Disease Program|
|Denver, Colorado, United States, 80206|
|Principal Investigator:||Jeff Swigris, DO, MS||National Jewish Health|